NovoCure (NASDAQ:NVCR) PT Lowered to $18.00
NovoCure (NASDAQ:NVCR – Get Free Report) had its price target lowered by stock analysts at Evercore ISI from $21.00 to $18.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has an “in-line” rating on the medical equipment provider’s stock. Evercore ISI’s price target suggests a potential upside of 16.13% […]
3 Oct 08:58 · The Markets Daily